SIM
BSPM

Spark Investment Management’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Spark Investment Management’s Portfolio BSPM Stock Details BSPM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,786
Closed -$22K – 827
2014
Q4 		$22K Sell
2,786
-771
-22% -$7.33K ﹤0.01% 671
2014
Q3 		$40K Sell
3,557
-2,343
-40% -$26.1K 0.01% 643
2014
Q2 		$59K Sell
5,900
-2,543
-30% -$28.1K 0.01% 589
2014
Q1 		$119K Buy
8,443
+2,486
+42% +$39.4K 0.02% 594
2013
Q4 		$85K Buy
+5,957
New +$64.4K 0.01% 574

Other funds holding BSPM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Spark Investment Management's BSPM Position: Q1 2015 in Review

Spark Investment Management sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q1 2015, closing a stake of 2,786 shares — an estimated $22K sold.

Spark Investment Management first reported a position in BSPM in Q4 2013 and held it in 5 quarters. The position peaked at $119K in Q1 2014. 9 funds tracked by Wall St. Rank hold BSPM as of Q1 2015.

  • Spark Investment Management reported no remaining Biostar Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Spark Investment Management sold 2,786 Biostar Pharmaceuticals, Inc. shares in Q1 2015, an estimated $22K.
  • Spark Investment Management first reported a position in Biostar Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
  • Spark Investment Management's Biostar Pharmaceuticals, Inc. position peaked at $119K in Q1 2014.
  • 9 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q1 2015.

Based on Spark Investment Management's 13F filing for Q1 2015, filed 12 May 2015.